DAP12介导小胶质细胞活化在神经系统中作用的研究进展
Research Progress on the Role of DAP12 Mediated Microglia Activation in Nervous System
DOI: 10.12677/ACM.2022.12121728, PDF,    科研立项经费支持
作者: 张 童, 姚 境:济宁医学院临床医学院,山东 济宁;李道静, 齐子有*:济宁医学院附属医院神经内科,山东 济宁
关键词: DAP12小胶质细胞神经系统疾病DAP12 Microglia Nervous System Disease
摘要: DNAX活化蛋白12 (DNAX-activating protein of 12 kDa, DAP12)是一种I型跨膜蛋白,在中枢神经系统(Central Nervous System, CNS)中主要表达于小胶质细胞,是将小胶质细胞从稳态转变为神经疾病相关状态的主要调节因子。DAP12信号通路可以通过调节小胶质细胞活性,参与许多神经系统疾病的免疫病理机制,如Nasu-Hakola病、阿尔茨海默病、帕金森病、缺血性卒中和神经病理性疼痛等,而且在不同疾病模型中发挥不同的调节作用。本文将就DAP12介导的小胶质细胞活化对神经系统生长发育以及神经系统疾病的调节机制进行深入阐述。
Abstract: DNAX-activating protein of 12 kDa (DAP12) is a type I transmembrane adapter protein mainly ex-pressed in microglia in Central Nervous System (CNS), which is a major regulator of the transition of microglia from homeostasis to a neuropathy-related state. DAP12 signaling pathway is involved in immunopathological mechanisms of many nervous system disease by regulating microglia activity, such as Nasu-Hakola disease, Alzheimer’s disease, Parkinson’s disease, ischemic stroke and neuropathic pain. And it plays different regulatory roles in different disease models. In this paper, DAP12-mediated microglia activation will be further elaborated on the growth and development of the nervous system and the regulatory mechanism of neurological diseases.
文章引用:张童, 姚境, 李道静, 齐子有. DAP12介导小胶质细胞活化在神经系统中作用的研究进展[J]. 临床医学进展, 2022, 12(12): 11992-11999. https://doi.org/10.12677/ACM.2022.12121728

参考文献

[1] Konishi, H. and Kiyama, H. (2018) Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases. Frontiers in Cellular Neuroscience, 12, Article 206. [Google Scholar] [CrossRef] [PubMed]
[2] Nimmerjahn, A., Kirchhoff, F. and Helmchen, F. (2005) Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo. Science, 308, 1314-1318. [Google Scholar] [CrossRef] [PubMed]
[3] Fernández-Arjona, M.D.M., Grondona, J.M., Granados-Durán, P., Fernández-Llebrez, P. and López-Ávalos, M.D. (2017) Microglia Morphological Categorization in a Rat Model of Neuroinflammation by Hierarchical Cluster and Principal Components Analysis. Frontiers in Cellular Neuroscience, 11, Article 235. [Google Scholar] [CrossRef] [PubMed]
[4] Kwon, H.S. and Koh, S.H. (2020) Neuroinflammation in Neuro-degenerative Disorders: The Roles of Microglia and Astrocytes. Translational Neurodegeneration, 9, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
[5] Kierdorf, K. and Prinz, M. (2013) Factors Regulating Microglia Activation. Frontiers in Cellular Neuroscience, 7, Article 44. [Google Scholar] [CrossRef] [PubMed]
[6] Campbell, K.S. and Colonna, M. (1999) DAP12: A Key Accessory Protein for Relaying Signals by Natural Killer Cell Receptors. The International Journal of Biochemistry & Cell Biology, 31, 631-636. [Google Scholar] [CrossRef
[7] Yuan, P., Condello, C., Keene, C.D., et al. (2016) TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron, 90, 724-739. [Google Scholar] [CrossRef] [PubMed]
[8] Kaifu, T., Nakahara, J., Inui, M., et al. (2003) Osteopetrosis and Thalamic Hypomyelinosis with Synaptic Degeneration in DAP12-Deficient Mice. Journal of Clinical Investigation, 111, 323-332. [Google Scholar] [CrossRef
[9] Paradowska-Gorycka, A. and Jurkowska, M. (2013) Structure, Expression Pattern and Biological Activity of Molecular Complex TREM-2/DAP12. Human Immunology, 74, 730-737. [Google Scholar] [CrossRef] [PubMed]
[10] Konishi, H. and Kiyama, H. (2020) Non-Pathological Roles of Microglial TREM2/DAP12: TREM2/DAP12 Regulates the Physiological Functions of Microglia from Development to Aging. Neurochemistry International, 141, Article ID: 104878. [Google Scholar] [CrossRef] [PubMed]
[11] Squarzoni, P., Oller, G., Hoeffel, G., et al. (2014) Microglia Modulate Wiring of the Embryonic Forebrain. Cell Reports, 8, 1271-1279. [Google Scholar] [CrossRef] [PubMed]
[12] Pont-Lezica, L., Beumer, W., Colasse, S., Drexhage, H., Versnel, M. and Bessis, A. (2014) Microglia Shape Corpus Callosum Axon Tract Fasciculation: Functional Impact of Prenatal Inflammation. European Journal of Neuroscience, 39, 1551-1557. [Google Scholar] [CrossRef] [PubMed]
[13] Parkhurst, C.N., Yang, G., Ninan, I., et al. (2013) Microglia Promote Learning-Dependent Synapse Formation through Brain-Derived Neurotrophic Factor. Cell, 155, 1596-1609. [Google Scholar] [CrossRef] [PubMed]
[14] Zhai, Q., Li, F., Chen, X., et al. (2017) Triggering Receptor Expressed on Myeloid Cells 2, a Novel Regulator of Immunocyte Phenotypes, Confers Neuroprotection by Relieving Neuroinflammation. Anesthesiology, 127, 98-110. [Google Scholar] [CrossRef
[15] Mazaheri, F., Snaidero, N., Kleinberger, G., et al. (2017) TREM2 Deficiency Impairs Chemotaxis and Microglial Responses to Neuronal Injury. EMBO Reports, 18, 1186-1198. [Google Scholar] [CrossRef] [PubMed]
[16] Filipello, F., Morini, R., Corradini, I., et al. (2018) The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. Immunity, 48, 979-991.e8. [Google Scholar] [CrossRef] [PubMed]
[17] Wakselman, S., Béchade, C., Roumier, A., Bernard, D., Triller, A. and Bessis, A. (2008) Developmental Neuronal Death in Hippocampus Requires the Microglial CD11b Integrin and DAP12 Immunoreceptor. Journal of Neuroscience, 28, 8138-8143. [Google Scholar] [CrossRef
[18] Wlodarczyk, A., Holtman, I.R., Krueger, M., et al. (2017) A Novel Microglial Subset Plays a Key Role in Myelinogenesis in Developing Brain. The EMBO Journal, 36, 3292-3308. [Google Scholar] [CrossRef] [PubMed]
[19] Zheng, H., Jia, L., Liu, C.C., et al. (2017) TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway. Journal of Neuroscience, 37, 1772-1784. [Google Scholar] [CrossRef
[20] Jay, T.R., von Saucken, V.E., Muñoz, B., et al. (2019) TREM2 Is Required for Microglial Instruction of Astrocytic Synaptic Engulfment in Neurodevelopment. Glia, 67, 1873-1892. [Google Scholar] [CrossRef] [PubMed]
[21] Linnartz-Gerlach, B., Bodea, L.G., Klaus, C., et al. (2019) TREM2 Triggers Microglial Density and Age-Related Neuronal Loss. Glia, 67, 539-550. [Google Scholar] [CrossRef] [PubMed]
[22] Sasaki, A., Kakita, A., Yoshida, K., et al. (2015) Variable Expression of Microglial DAP12 and TREM2 Genes in Nasu-Hakola Disease. Neurogenetics, 16, 265-276. [Google Scholar] [CrossRef] [PubMed]
[23] Thrash, J.C., Torbett, B.E. and Carson, M.J. (2009) Develop-mental Regulation of TREM2 and DAP12 Expression in the Murine CNS: Implications for Nasu-Hakola Disease. Neurochemical Research, 34, 38-45. [Google Scholar] [CrossRef] [PubMed]
[24] Miron, V.E., Boyd, A., Zhao, J.W., et al. (2013) M2 Microglia and Macrophages Drive Oligodendrocyte Differentiation during CNS Remyelination. Nature Neuroscience, 16, 1211-1218. [Google Scholar] [CrossRef] [PubMed]
[25] Cantoni, C., Bollman, B., Licastro, D., et al. (2015) TREM2 Regulates Microglial Cell Activation in Response to Demyelination in Vivo. Acta Neuropathologica, 129, 429-447. [Google Scholar] [CrossRef] [PubMed]
[26] Poliani, P.L., Wang, Y., Fontana, E., et al. (2015) TREM2 Sus-tains Microglial Expansion during Aging and Response to Demyelination. Journal of Clinical Investigation, 125, 2161-2170. [Google Scholar] [CrossRef
[27] Jonsson, T., Stefansson, H., Steinberg, S., et al. (2013) Variant of TREM2 Associated with the Risk of Alzheimer’s Disease. The New England Journal of Medicine, 368, 107-116. [Google Scholar] [CrossRef
[28] Guerreiro, R., Wojtas, A., Bras, J., et al. (2013) TREM2 Variants in Alzheimer’s Disease. The New England Journal of Medicine, 368, 117-127. [Google Scholar] [CrossRef
[29] Zhang, B., Gaiteri, C., Bodea, L.G., et al. (2013) Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease. Cell, 153, 707-720. [Google Scholar] [CrossRef] [PubMed]
[30] Wang, Y., Ulland, T.K., Ulrich, J.D., et al. (2016) TREM2-Mediated Early Microglial Response Limits Diffusion and Toxicity of Amyloid Plaques. Journal of Experi-mental Medicine, 213, 667-675. [Google Scholar] [CrossRef] [PubMed]
[31] Ulland, T.K., Song, W.M., Huang, S.C., et al. (2017) TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease. Cell, 170, 649-663.e13. [Google Scholar] [CrossRef] [PubMed]
[32] Lee, C.Y.D., Daggett, A., Gu, X., et al. (2018) Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models. Neuron, 97, 1032-1048.e5. [Google Scholar] [CrossRef] [PubMed]
[33] Cui, X., Qiao, J., Liu, S., Wu, M. and Gu, W. (2021) Mecha-nism of TREM2/DAP12 Complex Affecting β-Amyloid Plaque Deposition in Alzheimer’s Disease Modeled Mice through Mediating Inflammatory Response. Brain Research Bulletin, 166, 21-28. [Google Scholar] [CrossRef] [PubMed]
[34] Jay, T.R., Hirsch, A.M., Broihier, M.L., et al. (2017) Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer’s Disease. Journal of Neuroscience, 37, 637-647. [Google Scholar] [CrossRef
[35] Hu, X., Zhang, D., Pang, H., et al. (2008) Macrophage Antigen Complex-1 Mediates Reactive Microgliosis and Progressive Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease. The Journal of Immunology, 181, 7194-7204. [Google Scholar] [CrossRef] [PubMed]
[36] Subramaniam, S.R. and Federoff, H.J. (2017) Targeting Mi-croglial Activation States as a Therapeutic Avenue in Parkinson’s Disease. Frontiers in Aging Neuroscience, 9, Article 176. [Google Scholar] [CrossRef] [PubMed]
[37] Virgone-Carlotta, A., Uhlrich, J., Akram, M.N., et al. (2013) Mapping and Kinetics of Microglia/Neuron Cell-to-Cell Contacts in the 6-OHDA Murine Model of Parkinson’s Disease. Glia, 61, 1645-1658. [Google Scholar] [CrossRef] [PubMed]
[38] Belloli, S., Pannese, M., Buonsanti, C., et al. (2017) Early Upregulation of 18-kDa Translocator Protein in Response to Acute Neurodegenerative Damage in TREM2-Deficient Mice. Neurobiology of Aging, 53, 159-168. [Google Scholar] [CrossRef] [PubMed]
[39] Guruswamy, R. and ElAli, A. (2017) Complex Roles of Microglial Cells in Ischemic Stroke Pathobiology: New Insights and Future Directions. International Journal of Molecular Sciences, 18, Article 496. [Google Scholar] [CrossRef] [PubMed]
[40] Jayaraj, R.L., Azimullah, S., Beiram, R, Jalal, F.Y. and Rosenberg, G.A. (2019) Neuroinflammation: Friend and Foe for Ischemic Stroke. Journal of Neuroinflammation, 16, Article No. 142. [Google Scholar] [CrossRef] [PubMed]
[41] Ma, Y., Wang, J., Wang, Y. and Yang, G.Y. (2017) The Biphasic Function of Microglia in Ischemic Stroke. Progress in Neurobiology, 157, 247-272. [Google Scholar] [CrossRef] [PubMed]
[42] Kawabori, M., Kacimi, R., Kauppinen, T., et al. (2015) Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke. Journal of Neuroscience, 35, 3384-3396. [Google Scholar] [CrossRef
[43] Sieber, M.W., Jaenisch, N., Brehm, M., et al. (2013) Attenuated Inflammatory Response in Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Knock-Out Mice Following Stroke. PLOS ONE, 8, e52982. [Google Scholar] [CrossRef] [PubMed]
[44] Wu, R., Li, X., Xu, P., et al. (2017) TREM2 Protects against Cerebral Ischemia/Reperfusion Injury. Molecular Brain, 10, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[45] Xu, P., Zhang, X., Liu, Q., et al. (2019) Microglial TREM-1 Receptor Mediates Neuroinflammatory Injury via Interaction with SYK in Experimental Ischemic Stroke. Cell Death & Disease, 10, Article No. 555. [Google Scholar] [CrossRef] [PubMed]
[46] Grace, P.M., Hutchinson, M.R., Maier, S.F. and Watkins, L.R. (2014) Pathological Pain and the Neuroimmune Interface. Nature Reviews Immunology, 14, 217-231. [Google Scholar] [CrossRef] [PubMed]
[47] Inoue, K. and Tsuda, M. (2018) Microglia in Neuropathic Pain: Cellular and Molecular Mechanisms and Therapeutic Potential. Nature Reviews Neuroscience, 19, 138-152. [Google Scholar] [CrossRef] [PubMed]
[48] Kobayashi, M., Konishi, H., Sayo, A., Takai, T. and Kiyama, H. (2016) TREM2/DAP12 Signal Elicits Proinflammatory Response in Microglia and Exacerbates Neuropathic Pain. Journal of Neuroscience, 36, 11138-11150. [Google Scholar] [CrossRef
[49] Guan, Z., Kuhn, J.A., Wang, X., et al. (2016) Injured Sensory Neuron-Derived CSF1 Induces Microglial Proliferation and DAP12-Dependent Pain. Nature Neuroscience, 19, 94-101. [Google Scholar] [CrossRef] [PubMed]
[50] Konishi, H., Kobayashi, M., Kunisawa, T., et al. (2017) Siglec-H Is a Microglia-Specific Marker That Discriminates Microglia from CNS-Associated Macrophages and CNS-Infiltrating Monocytes. Glia, 65, 1927-1943. [Google Scholar] [CrossRef] [PubMed]